By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in Molecular Imaging. According to news reporting originating from Geneva, Switzerland, by NewsRx correspondents, research stated, "Ultrasound contrast imaging techniques represent a real opportunity to improve efficiency in the preclinical drug discovery and development process. Ultrasound contrast agents (UCAs) combined with specific ultrasound contrast detection modes provide real-time, high spatial resolution of both organ and lesion blood perfusion, the so-called dynamic contrast-enhanced ultrasound imaging."
Our news editors obtained a quote from the research from Bracco Suisse SA, "With the advent of targeted UCA, ultrasound molecular imaging is gaining momentum in molecular imaging, particularly because of the simultaneous real-time anatomical and functional/molecular imaging capabilities. In preclinical research, contrast-enhanced ultrasound imaging, with either nontargeted or targeted UCA, is a fast-growing imaging modality that has not yet been standardized compared with other imaging modalities. Contrast-enhanced ultrasound imaging is an operator-dependent imaging modality, requiring adherence to rigorous step-by-step protocols. In this article, which is intended for advanced, hands-on researchers, we report key factors that can lead to variability in preclinical results and recommend some preventive methods to limit or cancel their effect on the final results."
According to the news editors, the research concluded: "Standardized procedures are a prerequisite for acceptance of new contrast-enhanced ultrasound imaging methods to eliminate factors that could distort results, improve the reproducibility between different centers and studies, and, therefore, allow translation to clinical application."
For more information on this research see: Use of ultrasound contrast agent microbubbles in preclinical research: recommendations for small animal imaging. Investigative Radiology, 2013;48(8):570-83. (Lippincott Williams and Wilkins - www.lww.com; Investigative Radiology - journals.lww.com/investigativeradiology/pages/default.aspx)
The news editors report that additional information may be obtained by contacting J.M. Hyvelin, Bracco Suisse SA, Geneva, Switzerland. Additional authors for this research include I. Tardy, C. Arbogast, M. Costa, P. Emmel, A. Helbert, M. Theraulaz, A.D. Nunn and F. Tranquart (see also Molecular Imaging).
Keywords for this news article include: Geneva, Europe, Switzerland, Nanotechnology, Molecular Imaging, Emerging Technologies.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC